Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11).
Juan Pablo FriasEnzo BonoraLuis Nevarez RuizYing G LiZhuoxin YuZvonko MilicevicRaleigh MalikM Angelyn BethelDavid A CoxPublished in: Diabetes care (2021)
In patients with type 2 diabetes inadequately controlled by metformin, escalation from dulaglutide 1.5 mg to 3.0 mg or 4.5 mg provided clinically relevant, dose-related reductions in HbA1c and body weight with a similar safety profile.